A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery
====================================================================================================================

* Jeroen H A Creemers
* W Joost Lesterhuis
* Niven Mehra
* Winald R Gerritsen
* Carl G Figdor
* I Jolanda M de Vries
* Johannes Textor